How will a 2nd Trump administration shape #IRA implementation and drug pricing, the future of #MedicareAdvantage, #healthcare coverage, and key federal agencies? Answer these questions and more here: https://lnkd.in/ersjYtZQ
关于我们
Avalere, part of Avalere Health , is a strategic advisory company whose core purpose is to create innovative solutions to complex healthcare problems. Based in Washington, D.C., the firm delivers actionable insights, business intelligence tools, and custom analytics for leaders in healthcare business and policy. Avalere's experts span 200+ staff drawn from Fortune 500 healthcare companies, the federal government, and top consultancies and nonprofits. The firm offers advisory services on a wide range of healthcare business issues affecting healthcare companies. Avalere’s focus on strategy is supported by a rigorous, in-house analytic research group that uses public and private data to generate quantitative insight. Through events, publications and interactive programs, Avalere insights are accessible to a broad range of customers. Avalere sits within the Policy, Access, Value, and Evidence discipline of Avalere Health and collaborates with colleagues across the firm to offer actionable, thoughtful guidance to clients. Visit AvalereHealth.com to learn about our full Policy, Access, Value, and Evidence offering.
- 网站
-
https://www.avalere.com
Avalere的外部链接
- 所属行业
- 商务咨询服务
- 规模
- 201-500 人
- 总部
- Washington，DC
- 类型
- 上市公司
- 领域
- Health insurance and reform、Evidence-based medicine、Reimbursement and product commercialization、Health economics and outcome research、Healthcare networks、Post-acute and long-term care、Data analytics and modeling和Financial Services
地点
-
主要
获取路线
1201 New York Ave NW
Suite 1000
US，DC，Washington，20005
Avalere员工
-
Rob M. Carter
Practice Director of Avalere’s division that serves healthcare investors
-
Milena Sullivan
Managing Director, Healthcare Policy Practice at Avalere Health
-
John Neal
Managing Director @ Avalere Health | MBA, Market Access Strategy
-
Shirley Bachman
Managing Director @ Avalere Health, Commercialization and Market Access
动态
-
In the second installment of our #AI for health plans video series, #AvalereExperts are joined by Mia Bolton and Teddy Gedamu of Tenasol to share how plans are operationalizing enterprise clinical data. ?? Tune in to watch the full video: https://lnkd.in/gwZSurce #artificialintelligence #healthplans
-
Our #AvalereExperts had a great time connecting with new and old colleagues at the Copay, Reimbursement, and Access Congress! If you didn't get a chance to chat with Mark Gooding or Jessica Cortez, CPB, it's not too late--reach out here: https://shorturl.at/XluqF #COPAY24 #reimbursement #AvalereInAction
-
-
Avalere转发了
It’s the final day of #ISPOREU2024! Are you ready to practically apply the insights learned to reach more patients? There’s still time to connect with our experts. Schedule your meeting today at [email protected], or stop by Booth #1412 to meet the team! #ISPOREurope #ISPOR #WeAreAvalereHealth
-
-
?? REGISTRATION IS OPEN! ?? Kick off 2025 with an in-depth discussion on how #lifesciencesfirms, #healthplans, #patientadvocates, and other #healthcare stakeholders can find opportunity among uncertainty. Avalere president Sarah Alwardt and other #AvalereExperts will be discussing:?? ? Cost Pressures and Reimbursement Changes ??Scientific Progress and Policy Change ? Integrated Business Strategies Reserve your spot here: https://lnkd.in/edZMHYRf #AvalereOutlook2025
-
-
Avalere转发了
Today’s the day! Our very own Laura T. Housman, MPH, MBA, DrPH(c) is hosting our panel discussion at 11.45am on 'The Application of Indirect Burden of Disease Evidence in US Value Assessment and Ex-US HTA Submissions’ at #ISPOREU2024, with insights from Karl-Johan Myren (Alexion Pharmaceuticals, Inc.), and our experts, Taylor Schwartz, and Jan McKendrick. Join the team in room 211, level P2, to learn more about the indirect costs of patient care and their significance for value assessment and ex-US HTA submissions. Schedule your meeting with the team today at [email protected] #ISPOREurope #ISPOR #ValueAssessment #PatientCare #Patients #HTA #WeAreAvalereHealth
-
-
Don't miss Jessica Cortez, CPB and Mark Gooding at the Copay, Reimbursement, and Access Congress! Tomorrow they will be speaking on panels on optimizing coding and billing strategies and the legislative and regulatory landscape. Connect to learn more about Avalere's work and to schedule a meeting with them: https://lnkd.in/e7_rAUAk #copay2024 #reimbursement #AvalereInAction
-
Avalere转发了
Thank you Med Ad News for featuring our own Sarah Alwardt in the upcoming Healthcare Agency Roundtable! Read the full article to discover more of Sarah’s insights on how the outcome of the 2024 US election will impact healthcare. Learn more: https://lnkd.in/exhhrSz5 #Election2024 #HealthPolicy #WeAreAvalereHealth
-
Avalere转发了
Are you attending #ISPOREU2024? Join us for at Booth #1412 at 6pm tonight for a drinks reception and opportunity to catch up on the first day of action. Schedule your meeting with us at ISPOR today: [email protected] #ISPOREurope #ISPOR #MarketAccess #ValueAssessment #PatientCare #WeAreAvalereHealth
-
-
Meet #AvalereExperts at the Copay, Reimbursement, and Access Congress! Jessica Cortez, CPB will be speaking on a panel on optimizing coding and billing strategies and Mark Gooding will be speaking on another about the legislative and regulatory landscape. Details below! Connect to learn more about Avalere's work and schedule a meeting next week: https://lnkd.in/e7_rAUAk #copay2024 #reimbursement #AvalereInAction